SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-032130
Filing Date
2019-08-14
Accepted
2019-08-14 16:06:27
Documents
52
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ogen-10q_20190630.htm 10-Q 1276969
2 EX-31.1 ogen-ex311_6.htm EX-31.1 9440
3 EX-31.2 ogen-ex312_8.htm EX-31.2 9231
4 EX-32.1 ogen-ex321_9.htm EX-32.1 5785
5 EX-32.2 ogen-ex322_7.htm EX-32.2 5767
  Complete submission text file 0001564590-19-032130.txt   5559948

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ogen-20190630.xml EX-101.INS 1413049
7 XBRL TAXONOMY EXTENSION SCHEMA ogen-20190630.xsd EX-101.SCH 39741
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ogen-20190630_cal.xml EX-101.CAL 30009
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ogen-20190630_def.xml EX-101.DEF 140726
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ogen-20190630_lab.xml EX-101.LAB 280295
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ogen-20190630_pre.xml EX-101.PRE 227116
Mailing Address 4902 EISENHOWER BLVD SUITE 125 TAMPA FL 33634
Business Address 4902 EISENHOWER BLVD SUITE 125 TAMPA FL 33634 8132867900
ORAGENICS INC (Filer) CIK: 0001174940 (see all company filings)

IRS No.: 593410522 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32188 | Film No.: 191026289
SIC: 2834 Pharmaceutical Preparations